1. Home
  2. LSB vs CXAIW Comparison

LSB vs CXAIW Comparison

Compare LSB & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSB
  • CXAIW
  • Stock Information
  • Founded
  • LSB 2002
  • CXAIW N/A
  • Country
  • LSB China
  • CXAIW United States
  • Employees
  • LSB N/A
  • CXAIW 41
  • Industry
  • LSB
  • CXAIW EDP Services
  • Sector
  • LSB
  • CXAIW Technology
  • Exchange
  • LSB NYSE
  • CXAIW Nasdaq
  • Market Cap
  • LSB 22.3M
  • CXAIW N/A
  • IPO Year
  • LSB N/A
  • CXAIW N/A
  • Fundamental
  • Price
  • LSB $1.05
  • CXAIW $0.07
  • Analyst Decision
  • LSB
  • CXAIW
  • Analyst Count
  • LSB 0
  • CXAIW 0
  • Target Price
  • LSB N/A
  • CXAIW N/A
  • AVG Volume (30 Days)
  • LSB 819.8K
  • CXAIW 20.9K
  • Earning Date
  • LSB 07-22-2025
  • CXAIW 03-21-2025
  • Dividend Yield
  • LSB N/A
  • CXAIW N/A
  • EPS Growth
  • LSB N/A
  • CXAIW N/A
  • EPS
  • LSB N/A
  • CXAIW N/A
  • Revenue
  • LSB $79,415,311.00
  • CXAIW $7,200,000.00
  • Revenue This Year
  • LSB $39.33
  • CXAIW N/A
  • Revenue Next Year
  • LSB $75.61
  • CXAIW N/A
  • P/E Ratio
  • LSB N/A
  • CXAIW N/A
  • Revenue Growth
  • LSB N/A
  • CXAIW N/A
  • 52 Week Low
  • LSB $0.36
  • CXAIW $0.11
  • 52 Week High
  • LSB $6.82
  • CXAIW $0.14
  • Technical
  • Relative Strength Index (RSI)
  • LSB 50.39
  • CXAIW N/A
  • Support Level
  • LSB $0.93
  • CXAIW N/A
  • Resistance Level
  • LSB $1.48
  • CXAIW N/A
  • Average True Range (ATR)
  • LSB 0.11
  • CXAIW 0.00
  • MACD
  • LSB 0.03
  • CXAIW 0.00
  • Stochastic Oscillator
  • LSB 30.51
  • CXAIW 0.00

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: